Unichem Laboratories
Unichem Laboratories Share Price Chart
Unichem Laboratories last traded at ₹531.85 (2026-10-13). Over the past month the stock moved +0.3%, three months the stock moved +48.8%, year the stock moved +5.8%. Its closing range over 52 weeks is ₹283.80 – ₹574.00, with the latest close 7.3% below the high.
Closing prices up to 2026-10-13.
About Unichem Laboratories
Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas.[1]
Therapeutic Areas The company manufactures and markets APIs and pharmaceutical formulations as branded & non-branded generics. The company’s products cater to diverse therapeutic areas such as cardiology, gas, diabetology, gastroenterology psychiatry, neurology, antibacterial, anti-infective, and pain management. [1]
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Unichem Laboratories reported sales of ₹633.00 crore (+20.1%) and net profit of ₹41.00 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 633.00 | 70.00 | 11.00 | 41.00 | 5.89 |
| Mar 2026 | 575.00 | 48.00 | 8.00 | 11.00 | 1.55 |
| Dec 2025 | 521.00 | 45.00 | 9.00 | 264.00 | 37.54 |
| Sep 2025 | 579.00 | 66.00 | 11.00 | -12.00 | -1.69 |
| Jun 2025 | 527.00 | 22.00 | 4.30 | -10.00 | -1.49 |
| Mar 2025 | 587.00 | 84.00 | 14.00 | 53.00 | 7.52 |
| Dec 2024 | 533.00 | 86.00 | 16.00 | 58.00 | 8.22 |
| Sep 2024 | 507.00 | 55.00 | 11.00 | 25.00 | 3.50 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +21.9% | +14.4% | +35.9% | +9.1% | +14.2% | -2.3% | -2.0% | +20.1% |
| Operating profit growth | +511.1% | +177.4% | +236.0% | -45.0% | +20.0% | -47.7% | -42.9% | +218.2% |
| Net profit growth | – | -20.5% | – | -600.0% | -148.0% | +355.2% | -79.2% | – |
| EPS growth | – | -21.0% | – | -613.8% | -148.3% | +356.7% | -79.4% | – |
| OPM % | 11.0% | 16.0% | 14.0% | 4.3% | 11.0% | 9.0% | 8.0% | 11.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Unichem Laboratories reported sales of ₹2,202.00 crore (+4.3%) and net profit of ₹253.00 crore (+83.3%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2,202 | 184.00 | 8.00 | 253.00 | 35.91 |
| Mar 2025 | 2,111 | 265.00 | 13.00 | 138.00 | 19.53 |
| Mar 2024 | 1,785 | 87.00 | 5.00 | -94.00 | -13.32 |
| Mar 2023 | 1,343 | -46.00 | -3.00 | -202.00 | -28.72 |
| Mar 2022 | 1,270 | 72.00 | 6.00 | 33.00 | 4.70 |
| Mar 2021 | 1,235 | 91.00 | 7.00 | 34.00 | 4.87 |
| Mar 2020 | 1,104 | -49.00 | -4.00 | -60.00 | -8.55 |
| Mar 2019 | 1,180 | -74.00 | -6.00 | -24.00 | -3.38 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +44.8% | -6.4% | +11.9% | +2.8% | +5.7% | +32.9% | +18.3% | +4.3% |
| Operating profit growth | – | – | – | -20.9% | -163.9% | – | +204.6% | -30.6% |
| Net profit growth | -100.9% | – | – | -2.9% | -712.1% | – | – | +83.3% |
| EPS growth | -100.9% | – | – | -3.5% | -711.1% | – | – | +83.9% |
| OPM % | -6.0% | -4.0% | 7.0% | 6.0% | -3.0% | 5.0% | 13.0% | 8.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Unichem Laboratories.
Get Free AI Stock Analysis FREE →Latest News
-
USFDA concludes inspection at Unichem Laboratories’ Goa Formulation facility
-
Unichem Laboratories reports consolidated net profit of Rs 41.47 crore in the June 2026 quarter - Business Standard
-
Unichem Laboratories reports consolidated net profit of Rs 41.47 crore in the June 2026 quarter - Business Standard
-
Unichem Laboratories reports consolidated net profit of Rs 41.47 crore in the June 2026 quarter - Business Standard
-
Unichem Laboratories consolidated net profit declines 79.40% in the March 2026 quarter - Business Standard
-
Unichem Laboratories’ arm recalls 500-count bottles of Buspirone Hydrochloride Tablets
-
Unichem Lab - Quaterly Results
-
Unichem Laboratories Q2 Results: Exceptional item leads to net loss; Stock surges 5%
-
Unichem Laboratories Q2 Results: Exceptional item leads to net loss; Stock surges 5%
Frequently Asked Questions
What is the share price of Unichem Laboratories today?
Unichem Laboratories shares were last quoted at ₹531.85 (+0.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Unichem Laboratories?
Unichem Laboratories has a price-to-earnings (P/E) ratio of 12.66 and a price-to-book (P/B) ratio of 1.40. The industry P/E is 53.33.
What is the 52-week high and low of Unichem Laboratories?
The 52-week high of Unichem Laboratories is ₹685.95 and the 52-week low is ₹280.00.
What is the market cap of Unichem Laboratories?
The market capitalisation of Unichem Laboratories is about ₹3,858.24 crore.
How did Unichem Laboratories perform in its latest quarterly results?
In the latest quarter (Jun 2026), Unichem Laboratories reported sales of ₹633.00 crore (+20.1%) and net profit of ₹41.00 crore, compared with the same quarter last year.
Is Unichem Laboratories a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Unichem Laboratories has a 3-year ROE of 2.00%, 3-year profit growth of 35.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Unichem Laboratories?
Promoters hold about 70.22% of Unichem Laboratories.
Which sector does Unichem Laboratories belong to?
Unichem Laboratories belongs to the Pharmaceuticals & Drugs sector.